Firefly Neuroscience (AIFF) Share-based Compensation (2010 - 2026)
Firefly Neuroscience (AIFF) posted Share-based Compensation of $494042.0 for Q2 2026, up 16.79% on a QoQ basis from $423000.0 in Q1 2026, and up 31.3% year-over-year from $376269.0 in Q2 2025.
Powered by 
Analysis
Firefly Neuroscience (AIFF) Share-based Compensation (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported Share-based Compensation for 17 years, with the latest figure at $494042.0 in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 31.3% year-over-year to $494042.0 in Q2 2026; TTM through Jun 2026 was $494042.0, a 31.3% increase from a year earlier, with the FY2025 full-year figure at $749000.0, down 71.13% from the prior year.
- Share-based Compensation was $494042.0 for Q2 2026 at Firefly Neuroscience, up from $423000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $2.4 million in Q3 2024, with the low at $59000.0 in Q1 2024.
- Average Share-based Compensation over 5 years is $391922.2, with a median of $323554.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation sank 94.61% in 2022, then jumped 3019.23% in 2024.
- Over 5 years, Share-based Compensation stood at $88903.0 in 2022, then fell by 23.51% to $68000.0 in 2023, then jumped by 591.27% to $470061.0 in 2024, then sank by 55.32% to $210000.0 in 2025, then jumped by 135.26% to $494042.0 in 2026.
- The last three Share-based Compensation figures came in at $494042.0 (Q2 2026), $423000.0 (Q1 2026), and $210000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 45.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 20.01 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 38.40 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 3.00 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 6.89 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 12.00 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 6.00 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 3.80 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | 494,042.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 494,042.00 |
| Mar 31, 2026 | 423,000.00 |
| Dec 31, 2025 | 210,000.00 |
| Sep 30, 2025 | 397,032.00 |
| Jun 30, 2025 | 376,269.00 |
| Mar 31, 2025 | 476,741.00 |
| Dec 31, 2024 | 470,061.00 |
| Sep 30, 2024 | 2.43 Mn |
| Jun 30, 2024 | 117,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 78,000.00 |
| Jun 30, 2023 | 88,159.00 |
| Mar 31, 2023 | 288,172.00 |
| Dec 31, 2022 | 88,903.00 |
| Sep 30, 2022 | 398,319.00 |
| Jun 30, 2022 | 358,936.00 |
| Mar 31, 2022 | 229,966.00 |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.23 Mn |